PCD Montgomery is a medicare approved dialysis facility center in Montgomery, Alabama and it has 18 dialysis stations. It is located in Montgomery county at 1001 Forest Avenue, Montgomery, AL, 36106. You can reach out to the office of PCD Montgomery at (334) 269-9416. This dialysis clinic is managed and/or owned by Davita. PCD Montgomery has the following ownership type - Profit. It was first certified by medicare in December, 1977. The medicare id for this facility is 012505 and it accepts patients under medicare ESRD program.
| Name | PCD Montgomery |
|---|---|
| Location | 1001 Forest Avenue, Montgomery, Alabama |
| No. of Dialysis Stations | 18 |
| Medicare ID | 012505 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1001 Forest Avenue, Montgomery, Alabama, 36106 | |
| (334) 269-9416 | |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
| NPI Number | 1689176711 |
| Organization Name | Majestic Dialysis |
| Doing Business As | Renal Treatment Centers Southeast Lp |
| Address | 1510 Eastern Blvd Montgomery, Alabama, 36117 |
| Phone Number | (334) 260-8519 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
| NPI Number | 1760446199 |
| Organization Name | Physicians Choice Dialysis - Montgomery |
| Doing Business As | Physicians Choice Dialysis Of Alabama Llc |
| Address | 1001 Forest Avenue Montgomery, Alabama, 36106 |
| Phone Number | (334) 269-9416 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 56 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 16 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 67 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 612 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
| Adult patients getting regular peritoneal dialysis at the center | 26 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 240 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 93 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at PCD Montgomery with elevated calcium levels.
| Patients with hypercalcemia | 94 |
| Hypercalcemia patient months | 899 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 98 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 14 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 57 |
| Patient months included in arterial venous fistula and catheter summaries | 500 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 60 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 85 |
| Hospitalization Rate in facility | 213.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 334.2 |
| Hospitalization Rate: Lower Confidence Limit | 139.5 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at PCD Montgomery were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 27.7 |
| Readmission Rate: Lower Confidence Limit | 13.5 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at PCD Montgomery get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .9 (As Expected) |
| SIR: Upper Confidence Limit | 2.45 |
| SIR: Lower Confidence Limit | .23 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether PCD Montgomery's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 70 |
| Transfusion Rate in facility | 31.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 77.7 |
| Transfusion Rate: Lower Confidence Limit | 14 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at PCD Montgomery lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 490 |
| Mortality Rate in facility | 16.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.2 |
| Mortality Rate: Lower Confidence Limit | 12 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago
PCD East Montgomery Location: 6890 Winton Blount Blvd, Montgomery, Alabama, 36117 Phone: (334) 260-0671 |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 9 days ago